CRE Symposium 2024: ‘What’s new since FOXP2: New developments in speech and language neurobiology’

The Centre of Research Excellence - Translational Centre for Speech Disorders is delighted to co-host their Symposium 'What’s new since FOXP2: New developments in speech and language neurobiology’, with University College London (UCL) Great Ormond Street Institute of Child Health. 

Please join this event as we celebrate over 20 years of research since the groundbreaking identification of FOXP2 as a gene critically involved in speech and language development. You will learn about the most recent genetic and neuroimaging discoveries in the field of speech and language disorders from international experts, including Prof Vargha-Khadem (UCL) and Prof Fisher (Max Planck Institute for Psycholinguistics). The event will end with a panel discussion on implications for clinical practice and future research directions.

Speakers: 

A/Prof. Frederique Liegeois, University College London

Prof. Angela Morgan, Murdoch Children’s Research Institute

Prof. Simon Fisher, Max Planck Institute for Psycholinguistics

Prof. Faraneh Vargha-Khadem, University College London

Prof. David Amor, University of Melbourne

Dr. Else Eising, Max Planck Institute of Psycholinguistics

Prof. Ingrid Scheffer, University of Melbourne

Prof. Dianne Newbury, Oxford Brookes University

Prof. Michelle Luciano, University of Edinburgh

Prof. Saloni Krishnan, University of London

Prof. Michael Hildebrand, University of Melbourne

To access the full preliminary event program, please follow this link. 

*Due to the limited availability of seats, early registration is strongly recommended to ensure your participation.